US 12,006,361 B2
Albumin binding domain fusion proteins
John K. Cini, Blairstown, NJ (US); and Haomin Huang, Yardley, PA (US)
Assigned to SONNET BIOTHERAPEUTICS, INC., Princeton, NJ (US)
Filed by Sonnet BioTherapeutics, Inc., Princeton, NJ (US)
Filed on May 4, 2021, as Appl. No. 17/307,884.
Application 17/307,884 is a continuation of application No. 15/932,387, filed on Feb. 20, 2018, granted, now 11,028,166.
Claims priority of provisional application 62/459,975, filed on Feb. 16, 2017.
Claims priority of provisional application 62/459,981, filed on Feb. 16, 2017.
Prior Publication US 2022/0106392 A1, Apr. 7, 2022
Int. Cl. C07K 16/24 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); C07K 14/715 (2006.01); C07K 14/76 (2006.01); C07K 16/18 (2006.01); C07K 16/22 (2006.01); C07K 16/28 (2006.01); C07K 16/46 (2006.01); C12N 15/00 (2006.01); C12N 15/10 (2006.01); C12N 15/13 (2006.01); C12N 15/62 (2006.01); A61K 38/00 (2006.01); C12N 15/63 (2006.01)
CPC C07K 16/244 (2013.01) [A61K 39/001138 (2018.08); A61K 39/00114 (2018.08); A61K 39/3955 (2013.01); A61P 35/00 (2018.01); C07K 14/7155 (2013.01); C07K 16/18 (2013.01); C07K 16/22 (2013.01); C07K 16/2818 (2013.01); C07K 16/468 (2013.01); A61K 38/00 (2013.01); A61K 2039/6081 (2013.01); C07K 14/76 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2319/00 (2013.01); C12N 15/62 (2013.01); C12N 15/63 (2013.01); C12N 2510/00 (2013.01); C12N 2800/00 (2013.01)] 5 Claims
 
1. An IL-12 albumin binding domain fusion protein comprising the amino acid sequence of SEQ ID NO: 280.